- Home
- ICCC vs SGRP Comparison
ICCC vs SGRP Comparison
Compare ICCC & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- SGRP
- Stock Information
- Founded
- ICCC 1982
- SGRP 1967
- Country
- ICCC United States
- SGRP United States
- Employees
- ICCC N/A
- SGRP N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- SGRP Business Services
- Sector
- ICCC Health Care
- SGRP Consumer Discretionary
- Exchange
- ICCC Nasdaq
- SGRP Nasdaq
- Market Cap
- ICCC 45.9M
- SGRP 52.3M
- IPO Year
- ICCC 1987
- SGRP 1996
- Fundamental
- Price
- ICCC $5.11
- SGRP $1.94
- Analyst Decision
- ICCC
- SGRP
- Analyst Count
- ICCC 0
- SGRP 0
- Target Price
- ICCC N/A
- SGRP N/A
- AVG Volume (30 Days)
- ICCC 10.1K
- SGRP 72.8K
- Earning Date
- ICCC 02-25-2025
- SGRP 11-14-2024
- Dividend Yield
- ICCC N/A
- SGRP N/A
- EPS Growth
- ICCC N/A
- SGRP N/A
- EPS
- ICCC N/A
- SGRP 0.50
- Revenue
- ICCC $23,838,001.00
- SGRP $228,869,000.00
- Revenue This Year
- ICCC N/A
- SGRP N/A
- Revenue Next Year
- ICCC N/A
- SGRP N/A
- P/E Ratio
- ICCC N/A
- SGRP $3.92
- Revenue Growth
- ICCC 46.37
- SGRP N/A
- 52 Week Low
- ICCC $3.34
- SGRP $0.97
- 52 Week High
- ICCC $5.82
- SGRP $3.12
- Technical
- Relative Strength Index (RSI)
- ICCC 52.70
- SGRP 51.36
- Support Level
- ICCC $4.86
- SGRP $1.80
- Resistance Level
- ICCC $5.50
- SGRP $1.89
- Average True Range (ATR)
- ICCC 0.36
- SGRP 0.07
- MACD
- ICCC -0.03
- SGRP 0.01
- Stochastic Oscillator
- ICCC 39.06
- SGRP 84.62
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.